表紙
市場調査レポート

脳梗塞:世界の治験レビュー

Ischemic Stroke Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 308777
出版日 ページ情報 英文 82 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
脳梗塞:世界の治験レビュー Ischemic Stroke Global Clinical Trials Review, H2, 2014
出版日: 2014年07月21日 ページ情報: 英文 82 Pages
概要

当レポートでは、脳梗塞に関する臨床研究の最新動向について分析し、疾患治療法の概要や、治験における主要国、G7諸国およびE7(新興7カ国)における治験数および被験者採用の状況、地域フェーズ(相)段階別の進行状況、有望なスポンサー、各企業研究機関での研究の進行状況、有望な薬剤の比較といった情報をまとめてお届けします。

イントロダクション

  • 脳梗塞
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要5カ国における治験件数
    • 中南米の主要5カ国における治験件数

G7諸国での治験件数:中枢神経系の治験件数に対する脳梗塞の治験件数比率

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:中枢神経系の治験件数に対する脳梗塞の治験件数比率

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

脳梗塞治療薬の治験に携わっている主要企業

有望な薬剤

最新の治験ニュース 脳梗塞

治験のプロファイル

  • 主要企業の治験の概要
    • Eli Lilly and Company
    • 第一三共
    • Sanofi
    • H. Lundbeck A/S
    • C. H. Boehringer Sohn AG & Co. KG
    • AstraZeneca PLC
    • Pfizer Inc.
    • D-Pharm Ltd.
    • 三菱ケミカルホールディングス
    • Bayer AG
  • 代表的な研究機関・病院の治験の概要
    • Seoul National University Hospital
    • China Academy of Chinese Medical Sciences
    • National Institute of Neurological Disorders and Stroke
    • Xijing Hospital
    • University of Texas Health Science Center at Houston
    • Hallym University Medical Center
    • Erasmus MC
    • Charite - Universitatsmedizin Berlin
    • University of Cincinnati
    • University of California, San Diego

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2244CTIDB

GlobalData's clinical trial report, "Ischemic Stroke Global Clinical Trials Review, H2, 2014" provides data on the Ischemic Stroke clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ischemic Stroke. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ischemic Stroke. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Ischemic Stroke
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Ischemic Stroke to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Ischemic Stroke to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Ischemic Stroke
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Ischemic Stroke Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Ischemic Stroke
    • Jun 27, 2014: Lundbeck provides update on the development program for desmoteplase
    • May 05, 2014: Cytomedix Announces Results of RECOVER-Stroke Phase 2 Study
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • H. Lundbeck A/S
      • Clinical Trial Overview of H. Lundbeck A/S
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • D-Pharm Ltd.
      • Clinical Trial Overview of D-Pharm Ltd.
      • Mitsubishi Chemical Holdings Corporation
      • Clinical Trial Overview of Mitsubishi Chemical Holdings Corporation
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
    • Clinical Trial Overview of Top Institutes / Government
      • Seoul National University Hospital
      • Clinical Trial Overview of Seoul National University Hospital
      • China Academy of Chinese Medical Sciences
      • Clinical Trial Overview of China Academy of Chinese Medical Sciences
      • National Institute of Neurological Disorders and Stroke
      • Clinical Trial Overview of National Institute of Neurological Disorders and Stroke
      • Xijing Hospital
      • Clinical Trial Overview of Xijing Hospital
      • University of Texas Health Science Center at Houston
      • Clinical Trial Overview of University of Texas Health Science Center at Houston
      • Hallym University Medical Center
      • Clinical Trial Overview of Hallym University Medical Center
      • Erasmus MC
      • Clinical Trial Overview of Erasmus MC
      • Charite - Universitatsmedizin Berlin
      • Clinical Trial Overview of Charite - Universitatsmedizin Berlin
      • University of Cincinnati
      • Clinical Trial Overview of University of Cincinnati
      • University of California, San Diego
      • Clinical Trial Overview of University of California, San Diego
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Ischemic Stroke Therapeutics, Global, Clinical Trials by Region, 2014*
  • Ischemic Stroke Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Ischemic Stroke Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Ischemic Stroke to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Ischemic Stroke Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Ischemic Stroke Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Ischemic Stroke to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Ischemic Stroke Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Ischemic Stroke Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Ischemic Stroke Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Ischemic Stroke Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Ischemic Stroke Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Ischemic Stroke Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Ischemic Stroke Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Ischemic Stroke Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Ischemic Stroke Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lundbeck A/S, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by D-Pharm Ltd., 2014*
  • Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Chemical Holdings Corporation, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by China Academy of Chinese Medical Sciences, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Xijing Hospital, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Health Science Center at Houston, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Hallym University Medical Center, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cincinnati, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2014*

List of Figures

  • Ischemic Stroke Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Ischemic Stroke Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Ischemic Stroke Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Ischemic Stroke Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Ischemic Stroke Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Ischemic Stroke Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Ischemic Stroke Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Ischemic Stroke to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Ischemic Stroke Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Ischemic Stroke Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Ischemic Stroke to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Ischemic Stroke Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Ischemic Stroke Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Ischemic Stroke Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Ischemic Stroke Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Ischemic Stroke Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Ischemic Stroke Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Ischemic Stroke Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Ischemic Stroke Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top